ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 613327 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 613327; 2) Community: the network communities that were significantly associated with the response to NSC 613327; 3) Molecule: the relationships between components within communities and NSC 613327; 4) MDR: the compounds that were significantly associated with the NSC 613327.

NSC Compound Enrichment Correlation
NSC 727082 16-[3-Methoxy-4-(2-piperidin-1-yl ethoxy)benzylidene]-17-oxo-5-androsten-3a-yl acetate 0.0295480456086945 0.12125883
NSC 736198 Indenoisoquinoline derivative 0.0295480456086945 0.67647822
NSC 755427 Null 0.0295480456086945 0.33015047
NSC 107043 Null 0.0295480456086947 0.19120492
NSC 134459 Acetamide, N-(2-mercaptoethyl)-, benzoate (6CI, 7CI) 0.0295480456086947 0.54065553
NSC 176323 Camptothecin Derivative 0.0295480456086947 0.75688752
NSC 208885 Null 0.0295480456086947 -0.23251065
NSC 261726 ICN 4221 0.0295480456086947 0.16617052
NSC 361605 Uracil, 5-fluoro-1-[tetrahydro-5-oxo-3-(trimethylsiloxy)-2-furanyl]-, (2S,trans)- 0.0295480456086947 0.14946346
NSC 37432 2-Propen-1-one, 3-(2-hydroxyphenyl)-1-phenyl- (9CI) 0.0295480456086947 0.10814617
Total:75  Current:46    [First] [Prev] [Next] [Last]